{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:37:59Z","timestamp":1789195079085,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014028","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S33221N"],"award-info":[{"award-number":["1S33221N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G061119N"],"award-info":[{"award-number":["G061119N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["810685"],"award-info":[{"award-number":["810685"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejpb.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T07:29:29Z","timestamp":1633764569000},"page":"134-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery"],"prefix":"10.1016","volume":"169","author":[{"given":"Helena","family":"Braet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rahimi-Gorji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Debbaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghader","family":"Ghorbaniasl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Van Walleghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senne","family":"Cornelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cosyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Vervaet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Willaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Ceelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan C.","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.10.001_b0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.addr.2016.07.001","article-title":"Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis \u2014 Mission possible?","volume":"108","author":"Dakwar","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2021.10.001_b0010","series-title":"PIPAC: Pressurized IntraPeritoneal Aerosol Chemotherapy \u2013 Cancer under Pressure","author":"Reymond","year":"2014"},{"issue":"10","key":"10.1016\/j.ejpb.2021.10.001_b0015","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2217\/fon.10.100","article-title":"Intraperitoneal therapy for peritoneal cancer","volume":"6","author":"Lu","year":"2010","journal-title":"Futur. Oncol."},{"issue":"27","key":"10.1016\/j.ejpb.2021.10.001_b0020","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: Optimal management review","volume":"25","author":"S\u00e1nchez-Hidalgo","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2021.10.001_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/5180895","article-title":"Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research","volume":"2019","author":"Koumpa","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"issue":"2","key":"10.1016\/j.ejpb.2021.10.001_b0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.suronc.2014.03.004","article-title":"Intraperitoneal chemotherapy against peritoneal carcinomatosis: Current status and future perspective","volume":"23","author":"Kitayama","year":"2014","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.ejpb.2021.10.001_b0035","doi-asserted-by":"crossref","first-page":"14881","DOI":"10.1038\/s41598-019-51419-y","article-title":"Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer","volume":"9","author":"De Clercq","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2021.10.001_b0040","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat. Rep."},{"issue":"5","key":"10.1016\/j.ejpb.2021.10.001_b0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1470-2045(03)01074-X","article-title":"Intraperitoneal antineoplastic drug delivery: Rationale and results","volume":"4","author":"Markman","year":"2003","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.10.001_b0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: First evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejpb.2021.10.001_b0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/cancers12010034","article-title":"Overcoming drug resistance by taking advantage of physical principles: Pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"12","author":"Nadiradze","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejpb.2021.10.001_b0060","doi-asserted-by":"crossref","first-page":"20190010","DOI":"10.1515\/pp-2019-0010","article-title":"MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma","volume":"4","author":"Sgarbura","year":"2019","journal-title":"Pleura and Peritoneum"},{"key":"10.1016\/j.ejpb.2021.10.001_b0065","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919846402","article-title":"Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study","volume":"11","author":"Struller","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejpb.2021.10.001_b0070","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","article-title":"Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study","volume":"44","author":"Nowacki","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ejpb.2021.10.001_b0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5230\/jgc.2018.18.e37","article-title":"Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Cancer Patients with Peritoneal Metastasis (PM): Results of a Single-Center Experience and Register Study","volume":"18","author":"Gockel","year":"2018","journal-title":"J. Gastr. Cancer"},{"key":"10.1016\/j.ejpb.2021.10.001_b0080","doi-asserted-by":"crossref","unstructured":"W. Ceelen, H. Braet, G. Van Ramshorst, W. Willaert, W. Ceelen, Expert Opinion on Drug Delivery Intraperitoneal chemotherapy for peritoneal metastases\u00a0: an expert opinion, 5247 (2020). https:\/\/doi.org\/10.1080\/17425247.2020.1736551.","DOI":"10.1080\/17425247.2020.1736551"},{"issue":"5","key":"10.1016\/j.ejpb.2021.10.001_b0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11095-009-0031-z","article-title":"Drug delivery systems for intraperitoneal therapy","volume":"27","author":"Bajaj","year":"2010","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.ejpb.2021.10.001_b0090","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic Problems in Peritoneal Drug Administration: Tissue Penetration and Surface Exposure","volume":"89","author":"Dedrick","year":"1997","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ejpb.2021.10.001_b0095","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/02656736.2017.1312563","article-title":"Tumour tissue transport after intraperitoneal anticancer drug delivery","volume":"33","author":"Carlier","year":"2017","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.ejpb.2021.10.001_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/720858","article-title":"Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent","volume":"2013","author":"De Smet","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ejpb.2021.10.001_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mabi.201700024","article-title":"High-Pressure Nebulization as Application Route for the Peritoneal Administration of siRNA Complexes","volume":"17","author":"Minnaert","year":"2017","journal-title":"Macromol. Biosci."},{"issue":"7","key":"10.1016\/j.ejpb.2021.10.001_b0110","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cancers11070906","article-title":"Aerosolization of nanotherapeutics as a newly emerging treatment regimen for peritoneal carcinomatosis","volume":"11","author":"Shariati","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.ejpb.2021.10.001_b0115","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-019-2646-z","article-title":"High Pressure Nebulization (PIPAC) Versus Injection for the Intraperitoneal Administration of mRNA Complexes","volume":"36","author":"Shariati","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.10.001_b0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fphar.2019.00669","article-title":"Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx\u00ae) as Pressurized Intraperitoneal Aerosol Chemotherapy","volume":"10","author":"Robella","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.10.001_b0125","doi-asserted-by":"crossref","unstructured":"L. Van De Sande, M. Graversen, M. Hubner, M. Pocard, M. Reymond, M. Vaira, S. Cosyns, W. Willaert, W. Ceelen, Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (AbraxaneTM) for peritoneal carcinomatosis \u2013 a phase I first-in-human study, 3 (2018) 20180112. https:\/\/doi.org\/10.1515\/pp-2018-0112.","DOI":"10.1515\/pp-2018-0112"},{"key":"10.1016\/j.ejpb.2021.10.001_b0130","unstructured":"T.R. Van Oudheusden, H. Grull, P.Y.W. Dankers, I.H.J.T. De Hingh, Targeting the peritoneum with novel drug delivery systems in peritoneal carcinomatosis: a review of the literature, 35 (2015). http:\/\/ar.iiarjournals.org\/content\/35\/2\/627.short (accessed April 4, 2019)."},{"key":"10.1016\/j.ejpb.2021.10.001_b0135","doi-asserted-by":"crossref","unstructured":"A. Bhatt, A. Mehta, New treatment modalities for the management of peritoneal metastases, in: Manag. Perit. Metastases- Cytoreductive Surgery, HIPEC Beyond, Springer Singapore, 2018: pp. 469\u2013506. https:\/\/doi.org\/10.1007\/978-981-10-7053-2_20.","DOI":"10.1007\/978-981-10-7053-2_20"},{"key":"10.1016\/j.ejpb.2021.10.001_b0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2016.05.056","article-title":"Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals","volume":"235","author":"Sun","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.10.001_b0145","first-page":"7291","article-title":"Enhanced antitumor effects by docetaxel\/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer","volume":"10","author":"Fan","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2021.10.001_b0150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2016.05.010","article-title":"Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis","volume":"104","author":"Xu","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.10.001_b0155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jconrel.2017.06.020","article-title":"Advances in biomaterials for preventing tissue adhesion","volume":"261","author":"Wu","year":"2017","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejpb.2021.10.001_b0160","doi-asserted-by":"crossref","first-page":"1700848","DOI":"10.1002\/advs.201700848","article-title":"Black-Phosphorus-Incorporated Hydrogel as a Sprayable and Biodegradable Photothermal Platform for Postsurgical Treatment of Cancer","volume":"5","author":"Shao","year":"2018","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2021.10.001_b0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2021.10.001_b0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.actbio.2019.03.036","article-title":"A gellan-based fluid gel carrier to enhance topical spray delivery","volume":"89","author":"ter Horst","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2021.10.001_b0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpb.2019.06.015","article-title":"Development of a sprayable hydrogel formulation for the skin application of therapeutic antibodies","volume":"142","author":"Geh","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.10.001_b0180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejps.2017.06.029","article-title":"Sprayable Carbopol hydrogel with soluble beta-1,3\/1,6-glucan as an active ingredient for wound healing \u2013 Development and in-vivo evaluation","volume":"107","author":"Grip","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2021.10.001_b0185","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biomaterials.2018.04.057","article-title":"Tissue adhesive, rapid forming, and sprayable ECM hydrogel via recombinant tyrosinase crosslinking","volume":"178","author":"Kim","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2021.10.001_b0190","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijbiomac.2019.07.126","article-title":"Sprayable and injectable visible-light Kappa-carrageenan hydrogel for in-situ soft tissue engineering","volume":"138","author":"Tavakoli","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2021.10.001_b0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.procir.2015.11.001","article-title":"Pluronic F127 Hydrogel Characterization and Biofabrication in Cellularized Constructs for Tissue Engineering Applications","volume":"49","author":"Gioffredi","year":"2016","journal-title":"Procedia CIRP"},{"key":"10.1016\/j.ejpb.2021.10.001_b0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1100\/tsw.2003.15","article-title":"Rheology of biopolymer solutions and gels","volume":"3","author":"Picout","year":"2003","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ejpb.2021.10.001_b0205","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/app.30586","volume":"114","author":"Barba","year":"2009","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2021.10.001_b0210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biomaterials.2014.10.039","article-title":"Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer","volume":"37","author":"Cho","year":"2015","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ejpb.2021.10.001_b0215","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jconrel.2011.12.001","article-title":"Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors","volume":"158","author":"Bajaj","year":"2012","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejpb.2021.10.001_b0220","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00595-013-0674-6","article-title":"Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer","volume":"44","author":"Emoto","year":"2014","journal-title":"Surg. Today"},{"key":"10.1016\/j.ejpb.2021.10.001_b0225","doi-asserted-by":"crossref","unstructured":"G. Xu, B. Li, T. Wang, J. Wan, Y. Zhang, J. Huang, Y. Shen, Enhancing the anti-ovarian cancer activity of quercetin using a self-assembling micelle and thermosensitive hydrogel drug delivery system (2018). https:\/\/doi.org\/10.1039\/c8ra03274b.","DOI":"10.1039\/C8RA03274B"},{"issue":"4","key":"10.1016\/j.ejpb.2021.10.001_b0230","doi-asserted-by":"crossref","first-page":"1600262","DOI":"10.1002\/mabi.201600262","article-title":"Use of 5-Fluorouracil Loaded Micelles and Cisplatin in Thermosensitive Chitosan Hydrogel as an Efficient Therapy against Colorectal Peritoneal Carcinomatosis","volume":"17","author":"Yun","year":"2017","journal-title":"Macromol. Biosci."},{"issue":"1","key":"10.1016\/j.ejpb.2021.10.001_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10637-010-9499-y","article-title":"The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model","volume":"30","author":"Yu","year":"2012","journal-title":"Invest. New Drugs"},{"issue":"5","key":"10.1016\/j.ejpb.2021.10.001_b0240","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/ijms19051373","article-title":"Thermosensitive injectable hydrogel for simultaneous intraperitoneal delivery of doxorubicin and prevention of peritoneal adhesion","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2021.10.001_b0245","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejps.2018.12.007","article-title":"Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel","volume":"128","author":"Ren","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2021.10.001_b0250","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/pharmaceutics11080392","article-title":"Pharmacokinetic Profile and Anti-Adhesive Effect of Oxaliplatin-PLGA Microparticle-Loaded Hydrogels in Rats for Colorectal Cancer Treatment","volume":"11","author":"Abuzar","year":"2019","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2021.10.001_b0255","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2011.11.025","article-title":"An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels","volume":"158","author":"Zahedi","year":"2012","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.ejpb.2021.10.001_b0260","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1039\/c2nr30278k","article-title":"Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites","volume":"4","author":"Gong","year":"2012","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.ejpb.2021.10.001_b0265","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1513\/pats.200409-046TA","article-title":"Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery","volume":"1","author":"Heyder","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.ejpb.2021.10.001_b0270","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12885-019-5658-5","article-title":"Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"19","author":"Van de Sande","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejpb.2021.10.001_b0275","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","article-title":"Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"31","author":"G\u00f6hler","year":"2017","journal-title":"Surg. Endosc."},{"key":"10.1016\/j.ejpb.2021.10.001_b0280","doi-asserted-by":"crossref","unstructured":"A.H. Lefebvre, V.G. McDonell, Atomization and Sprays, Second, 2017.","DOI":"10.1201\/9781315120911"},{"issue":"1","key":"10.1016\/j.ejpb.2021.10.001_b0285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-matsci-070909-104502","article-title":"Inkjet Printing of Functional and Structural Materials: Fluid Property Requirements, Feature Stability, and Resolution","volume":"40","author":"Derby","year":"2010","journal-title":"Annu. Rev. Mater. Res."},{"key":"10.1016\/j.ejpb.2021.10.001_b0290","first-page":"100007","article-title":"Chitosan\/\u03b2-glycerophosphate in situ gelling mucoadhesive systems for intravesical delivery of mitomycin-C","volume":"1","author":"Kolawole","year":"2019","journal-title":"Int. J. Pharm. X"},{"issue":"16","key":"10.1016\/j.ejpb.2021.10.001_b0295","doi-asserted-by":"crossref","first-page":"2000655","DOI":"10.1002\/adhm.202000655","article-title":"Electrostatic Intraperitoneal Aerosol Delivery of Nanoparticles: Proof of Concept and Preclinical Validation","volume":"9","author":"Van de Sande","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2021.10.001_b0300","series-title":"Turbulent Modeling for CFD, second","author":"Wilcox","year":"2002"},{"key":"10.1016\/j.ejpb.2021.10.001_b0305","article-title":"Multiphase flow handbook","author":"Crowe","year":"2006","journal-title":"CRC Press"},{"issue":"2","key":"10.1016\/j.ejpb.2021.10.001_b0310","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcis.2006.10.073","article-title":"Controlled synthesis and association behavior of graft Pluronic in aqueous solutions","volume":"306","author":"Zhang","year":"2007","journal-title":"J. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2021.10.001_b0315","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cjce.5450630202","article-title":"Spray cone angle and its correlation in a high pressure fuel spray","volume":"63","author":"Varde","year":"1985","journal-title":"Can. J. Chem. Eng."},{"issue":"7","key":"10.1016\/j.ejpb.2021.10.001_b0320","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121002563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:45:35Z","timestamp":1760546735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121002563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":64,"alternative-id":["S0939641121002563"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.10.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}